Samsung Biologics nears full takeover of PolyPeptide
Samsung Biologics has secured acceptances for nearly 98 percent of the shares targeted in its tender offer for Switzerland-based PolyPeptide Group, clearing the threshold needed…
From the source
Read at pulse.mk.co.krSamsung Biologics nears full takeover of PolyPeptide
Samsung Biologics has secured acceptances for nearly 98 percent of the shares targeted in its tender offer for Switzerland-based PolyPeptide Group, clearing the threshold needed to acquire the remaining minority shares and take full ownership of the peptide drug manufacturing specialist.
Source URL https://pulse.mk.co.kr/news/all/12194350
